In this issue of Clinics in Laboratory Medicine, guest editor Dr. Marisa C. Neilsen brings her considerable expertise to the topic of Infectious Disease Diagnostics. Top experts discuss current guidelines for infectious diseases diagnostics and emerging technology in the field of clinical microbiology; cover the strengths and weaknesses of current testing strategies and how laboratory results are used to guide treatment and improve patient outcomes; and explore how laboratories can adapt to the dynamic endemicity of pathogens, increasing antimicrobial resistance, and pandemics.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Mass Spectrometry Revolution in Clinical Microbiology Part 1: History and Current Applications - p. 1 9. The Mass Spectrometry Revolution in Clinical Microbiology Part 2: Emerging Applications - p. 15 10. Molecular Diagnostics for Invasive Molds: From Lab to Bedside - p. 27 11. Interpretation of Bacterial Smears and Cultures Using Artificial Intelligence - p. 41 12. Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health: The Role of the Clinical Laboratory - p. 51 13. Herpes B Virus: Occupational Exposures and Diagnostics - p. 63 14. Diagnosing Chagas in Pregnancy and Childhood: What’s Old and New - p. 73 15. Current Trends in Identification and Susceptibility Testing of Mycobacteria - p. 87 16. Candida auris Diagnostics: Identification and Screening - p. 101 17. A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults - p. 111 18. Epidemiology and Diagnosis of Lyme Disease in the United States - p. 137 19. Diagnosis of Tick-Borne Diseases in New England - p. 145
In this issue of Clinics in Laboratory Medicine, guest editor Dr. Marisa C. Neilsen brings her considerable expertise to the topic of Infectious Disease Diagnostics. Top experts discuss current guidelines for infectious diseases diagnostics and emerging technology in the field of clinical microbiology; cover the strengths and weaknesses of current testing strategies and how laboratory results are used to guide treatment and improve patient outcomes; and explore how laboratories can adapt to the dynamic endemicity of pathogens, increasing antimicrobial resistance, and pandemics.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Mass Spectrometry Revolution in Clinical Microbiology Part 1: History and Current Applications - p. 1 9. The Mass Spectrometry Revolution in Clinical Microbiology Part 2: Emerging Applications - p. 15 10. Molecular Diagnostics for Invasive Molds: From Lab to Bedside - p. 27 11. Interpretation of Bacterial Smears and Cultures Using Artificial Intelligence - p. 41 12. Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health: The Role of the Clinical Laboratory - p. 51 13. Herpes B Virus: Occupational Exposures and Diagnostics - p. 63 14. Diagnosing Chagas in Pregnancy and Childhood: What’s Old and New - p. 73 15. Current Trends in Identification and Susceptibility Testing of Mycobacteria - p. 87 16. Candida auris Diagnostics: Identification and Screening - p. 101 17. A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults - p. 111 18. Epidemiology and Diagnosis of Lyme Disease in the United States - p. 137 19. Diagnosis of Tick-Borne Diseases in New England - p. 145
